MedTrace Logo

Symptomatic Carotid Outcomes Registry

NCT05300737 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 114

Last updated 2025-10-17

No results posted yet for this study

Summary

The purpose of this study is to build upon trials done over 30 years ago, which did not include statins, new antiplatelet agents, and newer antihypertensive medications. Since the landmark trials (NASCET, ECST), there have been new developments in medical stroke prevention, which creates a gap in knowledge. The aim of this study is to evaluate that clinical care with Intensive Medical Therapy (IMT) alone, the one year stroke rate in patients with symptomatic carotid stenosis and low risk clinical features will be \<5%.

Conditions

Interventions

OTHER

intensive medical therapy

Dual antiplatelet therapy, high potency statins, HTN control, lifestyle modification

Sponsors & Collaborators

  • University of Maryland, Baltimore

    lead OTHER

Principal Investigators

  • Seemant Chaturvedi, MD · School of Medicine, University of Maryland

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05300737 on ClinicalTrials.gov